South & Central America Newborn Screening Market Forecast to 2030
South & Central America Newborn Screening Market Forecast to 2030 – Regional Analysis – by Product Type (Reagents and Assay Kits, and Instruments), Technology [Tandem Mass Spectrometry (TMS), Molecular Assays, Immunoassays and Enzymatic Assays, Pulse Oximetry Screening Technology, and Others], Test Type [Dry Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) Test, and Others], and End User (Hospitals and Clinics, and Diagnostic Laboratories)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Genetic Screening of Newborns Fuels the South & Central America Newborn Screening Market
The demand for comprehensive genetic screening of newborns is rising with the deepening knowledge about the genetic causes of medical conditions and advancements in healthcare technologies. As a result, companies in the newborn screening market are developing innovative, cost-effective screening solutions. Yescarta and Zynteglo are two examples of authorized gene treatments for large B-cell lymphoma and beta-thalassemia. Further, the emergence of technologies conferring an ability to identify genetic predispositions to diseases at birth pave the way for personalized healthcare, aligning with the broader trend of precision medicine.
Screening for genetic diseases during pregnancy also focuses on the early detection of pregnancy-related problems. Next-generation sequencing aids in the prenatal screening of neonates with a sensitivity of above 95% for detecting aneuploidies (such as Down syndrome and Trisomy 21) or partial chromosomal abnormalities (duplications or deletions) in all chromosomes. Fluorescence in-situ hybridization (FISH) is employed to detect monogenic illnesses such as sickle cell anemia; it also aids in an effective preimplantation genetic diagnosis. Noninvasive procedures such as the cell-free fetal DNA approach using maternal plasma are the recent advancements in genetic tests. The embryonic DNA can be distinguished from maternal DNA pieces based on differences in their sizes. Real-time PCR with fluorescent probes, shotgun sequencing (Solexa or Illumina), or huge targeted parallel sequencing can be used to examine DNA associated with fetal medical conditions. This would allow doctors to provide early molecular interventions with certain pharmacological therapies (pharmacogenetics) and to transform cells, tissues, and organs physically and chemically if this type of genetic screening is further researched. Thus, advancements in methods for screening infants for genetic disorders hold immense potential for the overall newborn screening market.
South & Central America Newborn Screening Market Overview
The newborn screening market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. South & Central America is a region comprising 20 diversified countries in terms of geographic area, demographics, economy, society, ethnicity, and developing healthcare systems. Brazil, Argentina, and other South & Central American countries receive a comparatively low number of newborn screening programs than higher-income nations. This is mainly due to the economic, technical, and logistical constraints and differences in the social, cultural, and political backgrounds of each country in the region. The federal NewBorn Screening (NBS) program currently includes six conditions: Congenital Hypothyroidism, Cystic Fibrosis, galactosemia test, biotinidase deficiency, and Congenital Adrenal Hyperplasia in the region. Moreover, the newborn screening programs and capabilities in the region are continuously improving. Longstanding NBS programs in Chile, Costa Rica, Cuba, and Uruguay cover over 99% of newborns. The programs in Brazil, Mexico, and Argentina have increased their screening panels but require education, follow-up, legislation, and management improvements.
Brazil started its nationwide NBS program in 2001 with reference centers that covered more than 80% of newborns. This program includes six main conditions: Phenylketonuria, Congenital Hypothyroidism, hemoglobinopathies, Cystic Fibrosis, Congenital Adrenal Hyperplasia, and biotinidase deficiency. The National Neonatal Screening Program in Brazil is targeting to reach 100% of live births over the next few years. The country has also implemented the Extended NBS (ENBS) for other metabolic disorders through tandem mass spectrometer (TMS) screening in a few states. A law was passed in June 2021 by the government authority of Brazil, mandating that all states implement ENBS by June 2022, with a progressive expansion of the program to include lysosomal diseases, immunodeficiencies, and spinal muscular atrophy. Thus, the country has witnessed significant and sustained growth in the last few years, owing to the implementation of new programs, a rise in medical healthcare coverage, the enactment of new NBS laws, the expansion of the disease panel, and the higher involvement of government and public health authorities. Increasing the adoption of NBS/ENBS programs promotes early diagnosis and treatment in neonates, which prove to be the first step to improving health outcomes for patients.
South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Newborn Screening Market Segmentation
The South & Central America newborn screening market is segmented based on product type, technology, test type, end user, and country.
Based on product type, the South & Central America newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held a larger South & Central America newborn screening market share in 2022. The reagents and assay kits segment is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.
In terms of technology, the South & Central America newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held the largest South & Central America newborn screening market share in 2022.
Based on test type, the South & Central America newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held the largest South & Central America newborn screening market share in 2022.
By end user, the South & Central America newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held a larger South & Central America newborn screening market share in 2022.
Based on country, the South & Central America newborn screening market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America newborn screening market in 2022.
Bio-Rad Laboratories Inc, Masimo Corp, Medtronic Plc, PerkinElmer Inc, and Waters Corp are some of the leading companies operating in the South & Central America newborn screening market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to The Research Team’ research, the South & Central America newborn screening market was valued at US$ 58.08 million in 2022 and is expected to reach US$ 100.64 million by 2030, registering a CAGR of 7.1% from 2022 to 2030. Integration of machine learning and artificial intelligence in screening and rising burden of congenital diseases are among the critical factors attributed to the South & Central America newborn screening market expansion.
According to a study published in The Lancet Digital Health in April 2023, a new deep-learning artificial intelligence model can help screen newborns for the retinopathy of prematureness. With the increasing availability of genetic and clinical data, machine learning algorithms have the potential to improve the accuracy and efficiency of screening processes. These algorithms can analyze vast datasets, identifying subtle patterns and associations that traditional methods may miss. By integrating machine learning into newborn screening, healthcare providers can improve the early detection of genetic disorders, leading to more timely interventions and better outcomes for infants.
As machine learning models evolve and adapt, they can contribute to the ongoing refinement and personalization of newborn screening protocols. This innovation not only benefits the health of newborns but also presents a significant growth opportunity for companies working on solutions that intersect healthcare and artificial intelligence. Additionally, machine learning can further enhance newborn screening programs by decreasing the false positive rate, raising specificity and positive predictive value, and spotting previously unidentified metabolic patterns in data. Thus, artificial intelligence and machine learning-based newborn screening are poised to become a prominent future trend in the newborn screening market.
On the contrary, lack of uniformity in newborn screening policies and practices hampers the growth South & Central America newborn screening market.
Based on product type, the South & Central America newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held 72.7% share of the South & Central America newborn screening market in 2022, amassing US$ 42.25 million. It is projected to garner US$ 77.73 million by 2030 to expand at 7.9% CAGR during 2022-2030. The reagents and assay kits segment is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.
In terms of technology, the South & Central America newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held 32.2% share of the South & Central America newborn screening market in 2022, amassing US$ 18.69 million. It is projected to garner US$ 34.08 million by 2030 to expand at 7.8% CAGR during 2022-2030.
Based on test type, the South & Central America newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held 53.5% share of South & Central America newborn screening market in 2022, amassing US$ 31.10 million. It is projected to garner US$ 56.89 million by 2030 to expand at 7.8% CAGR during 2022-2030.
By end user, the South & Central America newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held 66.9% share of South & Central America newborn screening market in 2022, amassing US$ 38.87 million. It is projected to garner US$ 75.02 million by 2030 to expand at 8.6% CAGR during 2022-2030.
Based on country, the South & Central America newborn screening market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil held 61.5% share of South & Central America newborn screening market in 2022, amassing US$ 35.71 million. It is projected to garner US$ 65.24 million by 2030 to expand at 7.8% CAGR during 2022-2030.
Key players operating in the South & Central America newborn screening market are Bio-Rad Laboratories Inc, Masimo Corp, Medtronic Plc, PerkinElmer Inc, and Waters Corp, among others.
– In May 2023, Masimo launched Stork, a revolutionary home baby monitoring system. This innovative system offers parents insights into their baby’s health data, helping them learn more about and connect better with their baby. The Masimo Stork baby monitor system comprises several components and is available in multiple configurations. Masimo Stork Vitals+, the flagship solution, consists of a boot with a sensor, video camera, and mobile app.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America newborn screening market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America newborn screening market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the newborn screening market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Newborn Screening Market – Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Surging Government Funding for Newborn Screening
4.1.2 Rising Burden of Congenital Diseases
4.1.3 Increasing Prevalence of Newborn Disorders
4.2 Key Market Restraints
4.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
4.3 Key Market Opportunities
4.3.1 Genetic Screening of Newborns
4.4 Future Trends
4.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
4.5 Impact Analysis:
5. Newborn Screening Market – South & Central America Market Analysis
5.1 South & Central America Newborn Screening Market Revenue (US$ Mn), 2022 – 2030
6. South & Central America Newborn Screening Market – Revenue and Forecast to 2030 – by Product Type
6.1 Overview
6.2 South & Central America Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
6.3 Reagents and Assay Kits
6.3.1 Overview
6.3.2 Reagents and Assay Kits: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 South & Central America Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
6.4 Instruments
6.4.1 Overview
6.4.2 Instruments: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.1 South & Central America Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)
7. South & Central America Newborn Screening Market – Revenue and Forecast to 2030 – by Technology
7.1 Overview
7.2 South & Central America Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
7.3 Tandem Mass Spectrometry (TMS)
7.3.1 Overview
7.3.2 Tandem Mass Spectrometry (TMS): South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Molecular Assays
7.4.1 Overview
7.4.2 Molecular Assays: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Immunoassays and Enzymatic Assays
7.5.1 Overview
7.5.2 Immunoassays and Enzymatic Assays: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Pulse Oximetry Screening Technology
7.6.1 Overview
7.6.2 Pulse Oximetry Screening Technology: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Other Technologies
7.7.1 Overview
7.7.2 Other Technologies: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Newborn Screening Market – Revenue and Forecast to 2030 – by Test Type
8.1 Overview
8.2 South & Central America Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
8.3 Dry Blood Spot Test
8.3.1 Overview
8.3.2 Dry Blood Spot Test: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Hearing Screen Test
8.4.1 Overview
8.4.2 Hearing Screen Test: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Critical Congenital Heart Diseases (CCHD) Test
8.5.1 Overview
8.5.2 Critical Congenital Heart Diseases (CCHD) Test: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Other Test Types
8.6.1 Overview
8.6.2 Other Test Types: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Newborn Screening Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 South & Central America Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Newborn Screening Market – Country Analysis
10.1 South & Central America Newborn Screening Market, Revenue and Forecast to 2030
10.1.1 South & Central America Newborn Screening Market, by Country
10.1.1.1 Brazil
10.1.1.1.1 Brazil Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.1.2 Brazil: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
10.1.1.1.2.1 Brazil: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
10.1.1.1.2.2 Brazil: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
10.1.1.1.3 Brazil: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
10.1.1.1.4 Brazil: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.1.5 Brazil: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 Argentina
10.1.1.2.1 Argentina Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.2 Argentina: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
10.1.1.2.2.1 Argentina: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
10.1.1.2.2.2 Argentina: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
10.1.1.2.3 Argentina: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
10.1.1.2.4 Argentina: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.2.5 Argentina: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 Rest of South & Central America
10.1.1.3.1 Rest of South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.2 Rest of South & Central America: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
10.1.1.3.2.1 Rest of South & Central America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
10.1.1.3.2.2 Rest of South & Central America: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
10.1.1.3.3 Rest of South & Central America: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
10.1.1.3.4 Rest of South & Central America: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.3.5 Rest of South & Central America: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
11. South & Central America Newborn Screening Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in Newborn Screening Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 PerkinElmer Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Waters Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Bio-Rad Laboratories Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Masimo Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Medtronic Plc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South & Central America Newborn Screening Market Segmentation
Table 2. South & Central America Newborn Screening Market, by Reagents and Assay Kits – Revenue and Forecast to 2030 (US$ Million)
Table 3. South & Central America Newborn Screening Market, by Instruments – Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 7. Brazil Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 8. Brazil Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 9. Brazil Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 10. Argentina Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 11. Argentina Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 12. Argentina Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 13. Argentina Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 14. Argentina Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 15. Argentina Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of South & Central America Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of South & Central America Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of South & Central America Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of South & Central America Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 20. Rest of South & Central America Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of South & Central America Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 22. Recent Organic Growth Strategies in Newborn Screening Market
Table 23. Recent Inorganic Growth Strategies in the Newborn Screening Market
Table 24. Glossary of Terms, Newborn Screening Market
LIST OF FIGURES
Figure 1. South & Central America Newborn Screening Market Segmentation, By Country
Figure 2. Newborn Screening Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Newborn Screening Market Revenue (US$ Mn), 2022 – 2030
Figure 5. South & Central America Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
Figure 6. Reagents and Assay Kits: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Instruments: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. South & Central America Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 9. Tandem Mass Spectrometry (TMS): South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Molecular Assays: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Immunoassays and Enzymatic Assays: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Pulse Oximetry Screening Technology: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Other Technologies: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. South & Central America Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 15. Dry Blood Spot Test: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Hearing Screen Test: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Critical Congenital Heart Diseases (CCHD) Test: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Other Test Types: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. South & Central America Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 20. Hospitals and Clinics: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Diagnostic Laboratories: South & Central America Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. South & Central America Newborn Screening Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 23. South & Central America Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 24. Brazil Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Argentina Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Rest of South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Growth Strategies in Newborn Screening Market
The List of Companies – South & Central America Newborn Screening Market
1. Bio-Rad Laboratories Inc
2. Masimo Corp
3. Medtronic Plc
4. PerkinElmer Inc
5. Waters Corp
You must be logged in to post a review.
Reviews
There are no reviews yet.